Zojwalla Naseem 4
4 · Olema Pharmaceuticals, Inc. · Filed Mar 20, 2024
Insider Transaction Report
Form 4
Zojwalla Naseem
CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2024-03-18$4.87/sh+13,700$66,719→ 80,364 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-03-18−13,700→ 136,300 totalExercise: $4.87Exp: 2033-01-31→ Common Stock (13,700 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vested on February 1, 2024 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.